Search
for
Sort by
Research 30 of 65
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Cutaneous toxicities of new treatments for melanoma
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Network pharmacology and molecular docking analysis on potential molecular targets and mechanism of action of BRAF inhibitors for application in wound healing
- Targeted therapy in melanoma
- Synthetic Approaches for Pharmacologically Active Decorated Six-Membered Diazines
- Biological therapy in the treatment of melanoma
- Dermatologic Adverse Events from Cancer Treatments
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Management of Toxicities of Targeted Therapies
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Drug-induced acne
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Alopecia in Association with Malignancy: A Review
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Graft-versus-host disease with acute hair loss: A distinctive manifestation of chronic graft-versus-host disease
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- STABILITY INDICATING AN LC-ESI-MS/MS METHOD FOR THE QUANTIFICATION OF MINOXIDIL IN PHARMACEUTICAL DOSAGE FORMS
- Hair Changes due to Drugs
- Poster Abstracts
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer